MCHP vs. HCA
MCHP (Microchip Technology Incorporated) and HCA (HCA Healthcare, Inc.) are both stocks. MCHP operates in Semiconductors (Technology), while HCA operates in Medical Care Facilities (Healthcare). Over the past 10 years, MCHP returned 15.50%/yr vs 17.23%/yr for HCA. At a 0.31 correlation, their price movements are largely independent.
Performance
MCHP vs. HCA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MCHP achieves a 44.96% return, which is significantly higher than HCA's -22.49% return. Over the past 10 years, MCHP has underperformed HCA with an annualized return of 15.50%, while HCA has yielded a comparatively higher 17.23% annualized return.
MCHP
- 1D
- 3.43%
- 1M
- -7.33%
- YTD
- 44.96%
- 6M
- 37.15%
- 1Y
- 43.83%
- 3Y*
- 7.14%
- 5Y*
- 6.01%
- 10Y*
- 15.50%
HCA
- 1D
- -2.90%
- 1M
- -16.97%
- YTD
- -22.49%
- 6M
- -25.30%
- 1Y
- -5.36%
- 3Y*
- 10.82%
- 5Y*
- 12.59%
- 10Y*
- 17.23%
MCHP vs. HCA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
MCHP Microchip Technology Incorporated | 44.96% | 14.61% | -34.96% | 30.90% | -17.98% | 27.49% | 33.73% | 48.02% | -16.71% | 39.46% |
HCA HCA Healthcare, Inc. | -22.49% | 56.71% | 11.75% | 13.83% | -5.64% | 57.58% | 12.07% | 20.24% | 43.37% | 18.67% |
Correlation
The correlation between MCHP and HCA is 0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.03 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.19 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.29 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.31 |
Correlation (All Time) Calculated using the full available price history since Mar 11, 2011 | 0.31 |
Over the past year, the correlation between MCHP and HCA has dropped to 0.03 - well below their long-term average of 0.31, suggesting their price drivers have been diverging.
Fundamentals
MCHP:
$0.43
HCA:
$28.46
MCHP:
212.69
HCA:
12.70
MCHP:
3.21
HCA:
1.51
MCHP:
7.87
HCA:
1.14
MCHP:
$4.71B
HCA:
$75.60B
MCHP:
$2.72B
HCA:
$31.37B
MCHP:
$1.02B
HCA:
$15.60B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MCHP vs. HCA — Risk / Return Rank
MCHP
HCA
MCHP vs. HCA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Microchip Technology Incorporated (MCHP) and HCA Healthcare, Inc. (HCA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| MCHP | HCA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.21 | ||
| Sortino ratioReturn per unit of downside risk | +1.81 | ||
| Omega ratioGain probability vs. loss probability | 1.20 | 0.99 | +0.21 |
| Calmar ratioReturn relative to maximum drawdown | 1.28 | -0.16 | +1.44 |
| Martin ratioReturn relative to average drawdown | 3.40 | -0.51 | +3.91 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| MCHP | HCA | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.01 | -0.20 | +1.21 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.14 | 0.42 | -0.29 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.37 | 0.53 | -0.16 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.43 | 0.60 | -0.17 |
Drawdowns
MCHP vs. HCA - Drawdown Comparison
The maximum MCHP drawdown since its inception was -63.77%, which is greater than HCA's maximum drawdown of -54.74%. Use the drawdown chart below to compare losses from any high point for MCHP and HCA.
Loading charts...
Drawdown Indicators
| MCHP | HCA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -63.77% | -54.74% | -9.03% |
Max Drawdown (1Y)Largest decline over 1 year | -34.41% | -33.62% | -0.79% |
Max Drawdown (3Y)Largest decline over 3 years | -63.77% | -33.62% | -30.15% |
Max Drawdown (5Y)Largest decline over 5 years | -63.77% | -39.49% | -24.28% |
Max Drawdown (10Y)Largest decline over 10 years | -63.77% | -54.74% | -9.03% |
Current DrawdownCurrent decline from peak | -10.78% | -33.62% | +22.84% |
Average DrawdownAverage peak-to-trough decline | -16.71% | -11.03% | -5.68% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.93% | 10.49% | +2.44% |
Volatility
MCHP vs. HCA - Volatility Comparison
Microchip Technology Incorporated (MCHP) has a higher volatility of 14.52% compared to HCA Healthcare, Inc. (HCA) at 7.50%. This indicates that MCHP's price experiences larger fluctuations and is considered to be riskier than HCA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MCHP | HCA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.52% | 7.50% | +7.02% |
Volatility (6M)Calculated over the trailing 6-month period | 31.67% | 21.36% | +10.31% |
Volatility (1Y)Calculated over the trailing 1-year period | 43.78% | 27.25% | +16.53% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 44.07% | 29.85% | +14.22% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 41.86% | 32.63% | +9.23% |
Dividends
MCHP vs. HCA - Dividend Comparison
MCHP's dividend yield for the trailing twelve months is around 1.99%, more than HCA's 0.81% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
HCA HCA Healthcare, Inc. | 0.81% | 0.62% | 0.88% | 0.89% | 0.93% | 0.75% | 0.63% | 1.08% | 1.12% | 0.00% | 0.00% | 0.00% |
MCHP Microchip Technology Incorporated | 1.99% | 2.86% | 3.16% | 1.76% | 1.65% | 0.98% | 1.07% | 1.40% | 2.02% | 1.65% | 2.24% | 3.07% |
Financials
MCHP vs. HCA - Financials Comparison
This section allows you to compare key financial metrics between Microchip Technology Incorporated and HCA Healthcare, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
MCHP vs. HCA - Profitability Comparison
MCHP - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Microchip Technology Incorporated reported a gross profit of 967.30M and revenue of 1.31B. Therefore, the gross margin over that period was 73.8%.
HCA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, HCA Healthcare, Inc. reported a gross profit of 8.18B and revenue of 19.51B. Therefore, the gross margin over that period was 41.9%.
MCHP - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Microchip Technology Incorporated reported an operating income of 211.10M and revenue of 1.31B, resulting in an operating margin of 16.1%.
HCA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, HCA Healthcare, Inc. reported an operating income of 3.18B and revenue of 19.51B, resulting in an operating margin of 16.3%.
MCHP - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Microchip Technology Incorporated reported a net income of 116.40M and revenue of 1.31B, resulting in a net margin of 8.9%.
HCA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, HCA Healthcare, Inc. reported a net income of 1.88B and revenue of 19.51B, resulting in a net margin of 9.6%.
Frequently Asked Questions
MCHP and HCA have a correlation of 0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MCHP has higher volatility (14.52%) compared to HCA (7.50%). In terms of maximum drawdown, MCHP dropped -63.77% vs HCA's -54.74%.
MCHP currently has the higher Sharpe Ratio (1.01 vs -0.20), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MCHP and HCA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer